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Abstract The immunosuppressant drug FK-506 (3-20 ~tM) increased the open probability of ryanodine receptor calcium release channels, formed 
by incorporation of terminal cisternae vesicles from rabbit skeletal muscle into lipid bilayers, with cis (cytoplasmic) alcium concentrations between 
10 -7 M and 10 -3 M. FK-506 increased mean current and channel open time and induced long sojourns at subconductance levels that were between 
28% and 38% of the maximum conductance and were distinct from the ryanodine-induced subconductance level at about 45% of the maximum 
conductance. FK-506 relieved the Ca 2+ inactivation of the ryanodine receptor seen at 10 -3 M Ca 2+. The results are consistent with FK-506 removal 
of FK-506 binding protein from the ryanodine receptor [15]. 
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1. Introduction 
The ryanodine receptor has been identified as a major cal- 
cium release channel in internal membranes of many cell types 
including neurons [1], cardiac [2] and skeletal muscle [3-5]. 
Ryanodine receptors in skeletal muscle are located at the triad 
junction and extrajunctional TC membranes [6]. The massive 
cytoplasmic domain~ of ryanodine receptors form the 'feet' [7] 
which span the junctional gap between the transverse (T-) tu- 
bule and TC [8]. 
It has recently been shown that FK-BP12, a 12kDa protein 
which binds the immunosuppressant FK-506, is tightly asso- 
ciated with ryanodine receptors in muscle [9,10]. FK-BPs form 
a class of cis-trans proline isomerases first identified in human 
T cells and later in other cells [11,12]. The skeletal muscle 
ryanodine receptor contains proline residues close to the puta- 
tive transmembrane s gments [13] and a cis-trans isomerization 
of these residues may play a role in channel gating. FK-BP12, 
localized at the triad junction [9], could be involved in ryan- 
odine receptor activation during excitation-contraction cou- 
pling. 
A regulatory action of FK-BP12 on ryanodine receptors is 
suggested by observations that calcium uptake by FK-BP12 
deficient TC vesicles falls and caffeine-induced calcium release 
is enhanced [14]. The open probability of  ryanodine receptors 
is greater in FK-BP deficient vesicles than in native vesicles 
when cytoplasmic [Ca 2+] is 10 -7 and 10 -6 M, although little 
effect of  FK-BP dissociation is seen at 10 -5 M [Ca 2÷] [15]. 
FK-BP is removed from the ryanodine receptor by FK-506 [10] 
and addition of FK-506 to native vesicles activates ryanodine 
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Abbreviations." PMSF, phenylmethylsulphonyl fluoride; BSA, bovine 
serum albumin; DMSO, dimethyl sulfoxide; TES, N-tris- 
(hydroxymethyl)methyl-2-aminoethanesulphonic acid; BAPTA, 1,2- 
bis(2-aminophenoxy)ethane-N,N,N',N'-tetra-acetic cid; TC, terminal 
cisternae; Po, open probability; _r, mean current; S.E.M., standard error 
of the mean; r, coefficient of correlation. 
receptor channels when cytoplasmic [Ca 2÷] was 55 nM [15]. We 
show here that FK-506 activates ryanodine receptors in TC 
vesicles over the physiological range of cis (cytoplasmic) [Ca 2÷] 
between 10 -7 and 10 -3 M. FK-506 relieved the calcium-inactiva- 
tion of ryanodine receptor channels at c/s [Ca 2÷] above 10 -4 M. 
2. Materials and methods 
TC vesicles were prepared from the back and leg muscle of New 
Zealand rabbits as described by Saito et al. [16]. All buffers contained 
the protease inhibitors: leupeptin, 1gM, pepstatin A, 1/.tM, benzamid- 
ine 1 mM, PMSF 0.7 mM. Protein was assayed [17] using BSA as a 
standard. Stock solutions of FK-506, kindly supplied by Fujisawa 
Pharmaceutical Co., were prepared at either 5 mM in ethanol and 
stored at 4°C, or 60 mM in DMSO at -20°C. Final concentrations of 
ethanol and DMSO in the bilayer solution were 0.33% and 0.004%, 
respectively. 
Bilayers were formed from a mixture of palmitoyl-oleoyl-phosphati- 
dylethanolamine, palmitoyl-oleoyl-phosphatidylserine and palmitoyl- 
oleoyl-phosphatidylcholine (5 : 3:2, by volume) [18,19], obtained in 
chloroform from Avanti Polar Lipids (Alabaster, Alabama). The lipid 
mixture was dried under N2 and redissolved in n-decane at a final 
concentration of 50 mg/ml. Lipid bilayers were formed over apertures 
(diameter 150 gm-200/.tm) in the wall of 2 ml delrin cups. The cis 
chamber contained 250 mM CsC1, 10 mM TES and 1 mM CaCI2, pH 
7.5 and the trans chamber contained 50 mM CsC1, 10 mM TES and 0.6 
mM CaCI2, pH 7.5. TC vesicles (final concentration = 10 gg/ml) were 
added to the cis chamber. Cs ÷ was the major ion carrying current 
through the calcium channel. After incorporation, free [Ca 2÷] was var- 
ied by perfusing the cis side with solutions containing 2 mM BAPTA 
and titrated to the desired free [Ca 2÷] with CaCI2, using a Ca2÷-selective 
electrode (Radiometer). 
Voltage was controlled and single channel activity recorded via an 
Axopatch 200 amplifier (Axon Instruments). The cis and trans cham- 
bers were connected to the amplifier head stage by Ag/AgCI electrodes 
in agar salt-bridges. Current was monitored on an oscilloscope and 
stored on video tape using pulse code modulation. Data were filtered 
at 2 kHz (4-pole Bessel, -3 dB) and digitized via a TL-1 DMA interface 
(Axon Instruments) at 5 kHz. Data were analysed using an in-house 
program, Channel 2, developed by M. Smith and P.W. Gage. Parame- 
ters measured were mean current (I', the integral of the current divided 
by time), the open probability (Po, the sum of the open times/total time, 
measured over a period of at least 30 s) and the mean open time. 
Channel opening was defined as any event which reached 10-20% 
(depending on noise) of the maximum open amplitude. Multiple Gauss- 
ian functions were fitted to all-point histograms using PeakFit (Jandel). 
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Fig. 1. Characterisation f the ryanodine receptor calcium release channel. (A) Low channel activity with 10 -3 M cis [Ca 2÷] and activation of the 
channel by 10 -5 M cis [Ca 2÷] (with 0.6 x 10 -3 M trans [Ca2÷]). (B) Channel activity with 0.6 x 10 -3 M trans [Ca2*], 10 -7 M cis Ca 2+ and 2 mM ATP 
(top trace) and the effect of 20 pM ryanodine added to the cis chamber (lower trace). (C) The effect of reducing trans [Ca 2+] from 0.5 x 10 -3 M to 
1 × 10 -6 M, with 10 -5 cis [Ca2+]. 
3. Results 
Ryanodine receptor calcium release channel activity was re- 
corded at -40 mV (trans potential relative to cis), the zero 
current potential for chloride ions. Under our conditions with 
0.6 mM trans Ca 2+ (close to the estimated in vivo luminal 
[Ca2+]), ryanodine receptor channels howed flickering and 
bursts of activity with conductances typically between 200 and 
250 pS, with classical behaviour [20] in that: (i) the burst activity 
was more pronounced with micromotar cis (cytoplasmic) [Ca/+] 
than with millimolar cis [Ca 2÷] (Fig. 1A); (ii) the channel was 
active at 10-7M cis [Ca 2÷] with 2 mM cis ATP (Fig. 1B) and 
(iii) ryanodine (20 pM cis) induced a long-lived subconductance 
state of 80-100 pS. The single channel conductance of 200 to 
250 pS was lower than some reported values (see e.g. [21]), but 
is typical of Cs ÷ conductances seen with 250/50 (cis/trans) Cs ÷ 
and millimolar trans [Ca2+], where Ca 2÷ causes a reduction in 
conductance by competitively displacing Cs ÷ from the channel 
pore [22]. If trans [Ca 2+] was lowered to 10 -6 M, single channel 
conductance increased to values close to 500 pS (Fig. 1C). The 
more physiological 0.6 mM trans [Ca 2+] was used in the follow- 
ing experiments. 
Addition of 20 pM FK-506 to the cis chamber produced a
dramatic increase in the activity of channels with cis [Ca 2÷] 
between 10 -7 M and 10 -3 M. The increase in activity was largely 
due to the appearance of long sojourns at subconductance 
levels that were around 30% of the maximum single channel 
conductance, shown as levels F, near -4.7 pA (59 pS) in Fig. 
2Ab or -4.5pA (56 pS) in Fig. 2Bb. In addition to the substate 
activity, openings to the maximum current level were observed 
with FK-506 but were not significantly increased by exposure 
to FK-506: the increase in the open probability of the channel 
(see average results below) being due to the increase in subcon- 
ductance activity. 
The subconductance levels that dominated channel activity 
in the presence of FK-506 were stabilised, not induced, by the 
immunosuppressant: flickering activity to levels at about 30% 
of the maximum current was observed under control conditions 
(Fig. 2Aa and Ba) and induced asymmetries in the all-points 
histograms. Gaussian curves fitted to the histograms of control 
activity in Fig. 2Aa and Ba showed peaks at -4.4 pA and -5.5 
pA respectively (see legend to Fig. 2), i.e. at current levels that 
were close to the dominant subconductance peaks in the histo- 
grams for data from the same channels in the presence of 
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Fig. 2. Examples of the effect of FK-506 on ryanodine receptor calcium release channel activity with 10 -3 M c/s [Ca 2+] and 0.6 x 10 -3 M trans [Ca2+]. 
Two channels are shown: one, (A), showing flickering substate activity and infrequent flickering between the dosed (C) and fully open (O) states 
under control conditions; the second, (B), showing frequent flickering mostly between C and O in the control record. The histograms have been fitted 
with a multiple Gaussian function: the number of peaks fitted (n), r 2 values for the best fit and current levels (+ 1S.E.M.) for peaks having the highest 
probability are given in parentheses for each histogram. Aa: control, (n = 6; r 2 = 0.997; 0 + 0.01, -2.1 + 0.1 pA and -4.4 + 0.I pA). Ab: enhanced 
substate activity at F in the same channel several seconds after addition of20/aM FK-506 (n = 6; r 2 = 0.995; 0 + 0.01, -2.3 + 0.1 pA and -4.7 + 0.1 
pA). Ba: control (n = 6; r 2 = 0.985; 0 + 0.02 pA, -3.1 + 0.1 pA and -5.5 + 0.3 pA). Bb: enhanced substate activity at F with 20/aM FK-506 (n = 5; 
r 2 = 0.997; 0 + 0.07 pA, -3.1 + 0.1 pA, -4.5 + 0.02 pA and -16.4 _+ 0.1 pA). Bc: 10/aM ryanodine added in the presence of 20/aM FK-506 (n = 2; 
r 2 = 0.993; -0  + 0.3 pA and -7.0 + 0.01 pA). Note that the maximum current at about - 16 pA is not resolved in histograms in Aa, Ab or Ba. The 
all-points histograms include data from a 9 s continuous recording in A, or a 4 s recording in B. Unlabelled arrows in the histograms are at 0 pA, 
the dosed level. Solid lines and arrows labelled C, F and O are placed at levels corresponding to the peaks of Gaussian curves fitted to the histograms. 
The broken lines Aa, Ab and Ba are drawn by eye through brief transitions to the maximum conductance. 
FK-506 (Fig. 2Ab and Bb). Flickering channel openings to the 
FK-506-stabil ised current level (F), recorded under control 
condit ions in the absence of  FK-506, were more apparent at 
lower cis [Ca 2+] and are particularly well defined in the example 
of channel  activity shown in Fig. 3Ab. In general Gaussian 
curves fitted to the all-points histograms had very similar peaks 
under control condit ions and after addit ion of FK-506 (see e.g. 
Fig. 2 and Fig. 3). The curve fitting procedure detected a second 
subconductance p ak in the histograms, with a probabi l i ty sim- 
ilar to that of the FK-506-stabil ised peak, between - 2 pA and 
-3  pA (see legends to Figs. 2 and 3). This lower current level 
was seen in control  channels and was maintained with FK-506. 
Marked subconductance activity in the presence of FK-506 has 
also been reported in FK-BP deficient vesicles [15]. 
Ryanodine added to the cis chamber was able to lock the 
FK-506-activated channel into a level at about 45% of maxi- 
mum conductance (a 88pS substate in Fig. 2Bc), as it did in the 
absence of the immunosuppressant (e.g. Fig. 1B). The ryan- 
odine substate was distinct from the FK-506-stabil ised substate 
at 56 pS: the FK-506-stabil ised substate was no longer observed 
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Fig. 3. Activation of multiple ryanodine receptor calcium release channel activity by FK-506 with 2 mM cis ATE 10 -7 M cis [Ca :+] and 0.6 x 10 -3 
M trans [Ca2+]. The segments of recording are from one bilayer and were selected to show clear current levels. The histograms are for the data in 
each record only and have been fitted with a multiple Gaussian function. The results of the Gaussian fit are given in parentheses, asdefined in Fig. 
2. A: control activity. Aa: usual channel activity, mostly between closed (C) and fully opening levels (Oi) (n = 6; r 2 = 0.968; 0 + 0.02 pA, -3.2 + 0.1 
pA, -6.25 + 0.2 pA and - 15.1 + 0.1). Ab: an unusual burst of control activity between levels C and F1 (n = 6; r 2 = 0.986; 0 + 0.02 pA, -2.72 + 0.1 
pA, -4.9 + 0.1 pA and - 14.7 + 0.2 pA). B: channel activity several seconds after addition of 20 tiM FK-506 to the cis chamber. Ba: full flickering 
openings in two channels with activity between levels C, O~ and 02, and substate activity to level F~. Due to limitations of our analysis program, 
the histogram was was split into three segments, 0 to - 11 pA (n = 4; r 2 = 0.932; 0 + 0.1 pA, -3.3 + 0.1 pA, -6.1 + 0.1 and -8.8 + 0.06 pA), -9  
to -22 pA (n = 5; r 2 = 0.906; - 15.3 + 0.3 and -20.3 _+ 0.12 pA) and - 18 to -36 pA (n = 5; r 2 = 0.682; -20.3 + 0.27 pA and -31.4 _+ 0.4 pA). Bb: 
prolonged openings to levels Fj, F 2 and flickering to O~ and 02 (n = 7; r 2 = 0.974; 0 _+ 0.02 pA, -3.3 +- 0.05 pA, - 5.9 + 0.05 pA, and - 10.8 + 0.1 
pA). Unlabelled arrows in the histograms are at 0pA, the closed level. Lines and arrows labelled C, F,, F2, O,, 02 are at levels corresponding to the 
peaks of the Gaussian curves fitted to the histograms. Broken lines show levels fitted to the data by eye. 
in channel activity after addit ion of ryanodine (Fig. 2Bc). Over- 
all, the conductance of the FK-506-stabil ised substate varied 
between 30% and 40% of the single channel conductance, but 
was always lower than that of the ryanodine substate when 
ryanodine was added to an FK-506-activated channel. 
In addit ion to increasing the open probabil i ty of individual 
channels (see average results below), FK-506 induced activity 
in channels that had previously been silent: openings to two to 
three times the maximum single channel conductance were 
often observed, at all cis [Ca2÷], upon addit ion of  the immuno- 
suppressant. An  example of multiple channel activation by 
FK-506 at 10 -7 M cis [Ca 2÷] is shown in Fig. 3. Records in this 
figure were selected to illustrate distinct current levels: it should 
be noted that the maintained subconductance activity at level 
F in Ab was not frequently observed under control conditions. 
One channel was active in the bilayer before addit ion of 
FK-506, with 2 mM cis ATP (A), and a second channel was 
activated shortly after addit ion of FK-506 to the bilayer solu- 
t ion (B). The current levels (see legend to Fig. 3 for details of 
analysis) suggest that both channels responded in a similar 
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manner to the immunosuppressant drug. Openings to the max- 
imum single channel conductance (level Or) and to twice the 
maximum single channel conductance (level 02) were observed 
(Fig. 3Ba), with flickering subconductance activity (e.g. to level 
F0 that was similar to the subconductance activity seen in the 
control records (Fig. 3Aa and Ab). In some segments of the 
recording (Fig. 3Bb), openings to levels Ot and 02 became very 
brief and longer periods of channel activity at levels F~ and F 2 
were observed. We speculate that F2 represented a summation 
of the FK-506-stabilised substates from each of the two chan- 
nels. Level OF has been drawn at -20  pA, i.e. the sum of 
O~ + Ft, and some flickering activity at this level was seen. 
The data in Fig. 3 also shows that FK-506 induced a similar 
increase in substate activity with 10 -7 M cis [Ca 2+] and with 10 -3 
M cis [Ca 2+] (Fig. 2). The activation of ryanodine receptor 
calcium release channels by FK-506 was seen in 20 bilayers with 
cis [Ca 2+] between l0 -7 and l0 -3 M. The activation resulted in 
an increase in the mean current (f), in the open probability (Po) 
and open times of single channels (see section 2) where these 
could be measured. Average data is summarised in the follow- 
ing paragraphs. 
The immunosuppressant drug was able to activate channels 
that had been inactivated by l0 -3 M cis [Ca2+]. This is illustrated 
in Fig. 2 (above) and was seen in 8 out of 8 bilayers. Four of 
these bilayers demonstrated only single channel activity before 
addition of FK-506 and additional channels were activated by 
the immunosuppressant, with an increase in I '  in these four 
bilayers from an average control value of -0.68 _+ 0.35 pA 
(mean _+ S.E.M.) to - 3.05 -+ 1.23 pA with FK-506. Single chan- 
nel activity in the remaining four bilayers was maintained after 
addition of FK-506, and Po of the single channel increased 
fivefold from 0.06 _+ 0.01 to 0.29 _+ 0.12. The average open time 
increased from 1.56 _+ 0.59 ms to 3.6 _+ 0.68 ms and I '  increased 
threefold from -1.16 _+ 0.32 pA to -3.03 + 0.25 pA. 
Mayrleitner et al. [15] found no difference between Po in 
control and FK-BP deficient vesicles at l0 -5 M cis [Ca 2+] when 
2 mM ATP was present. However, we have found that, in the 
absence of cis ATE addition of 3-4/l M FK-506 (in DMSO) 
increased the activity of Ca 2÷ channels in 5 bilayers with 10 -5 
M cis [Ca2+]. Multiple channel activity was induced by addition 
of FK-506 in four of these bilayers. Single channel activity 
persisted in one of the bilayers after addition of 3/1M FK-506 
and Po in this channel increased from 0.1 to 0.4. The average 
I '  (n = 5) increased from -3.6 _+ 1.2 to -7.7 _+ 2.4 pA. It is 
probable that, when channels are nearly maximally activated 
with 2 mM ATP and 10 -5 M cis Ca 2÷, additional activation by 
FK-BP removal may not be detected. In our hands, an effect of 
FK-506 was not obvious in highly active channels. For example 
in one bilayer containing two active channels, I '  was - 31 pA be- 
fore, and -26 pA after addition of 6/1M FK-506 when the [Ca 2÷] 
in the cis solution was 10 -4 M Ca z~ and the [ATP] = 2 mM. 
Several lines of evidence suggested that FK-506 specifically 
interacted with the ryanodine receptor complex. Addition of 
ryanodine eliminated the FK-506-stabilised substate and 
locked the channel into a higher conductance ryanodine sub- 
state (Fig. 3Bc above). This observation implied that the sub- 
maximal current activated by FK-506 flowed through the ryan- 
odine receptor channel and not a separate channel. In addition, 
FK-506 (a) did not induce channel activity when added to the 
bilayer alone, (b) neither altered the activity of chloride chan- 
nels, nor induced additional channel activity in bilayers 
demonstrating chloride channels, but not ryanodine receptor 
calcium channels and (c) addition of 0.33% ethanol alone to the 
cis chamber did not alter ryanodine receptor channel activity 
(n = 3). 
The effect of FK-506 could not be reversed by washing the 
bilayer chambers with drug-free solutions (n = 2). In one exam- 
ple with 10 -4 M cis Ca 2÷, Po increased from 0.02 to 0.43 upon 
addition of 6/1M FK-506 and remained high (0.52) following 
washout of the cis chamber. This observation is consistent with 
the proposition that FK-506 acted by removing FK-BP from 
the ryanodine receptor, although the FK-506 may have been 
difficult to remove from the bilayer because of its lipophilic 
nature. 
4. Discussion 
The results how clearly that FK-506 alters the gating char- 
acteristics of the ryanodine receptor calcium release channel in 
native TC vesicles. The channel was activated by FK-506 with 
cis [Ca 2÷] ranging from 10 -7 to 10 -3 M. The mean current in 
bilayers increased because the immunosuppressant c ivated 
additional channels and because the single channel occupancy 
of a subconductance state, at 3(~40% of the maximum channel 
conductance, was increased. Brief transitions to this substate 
were observed under control conditions, indicating that the 
subconductance level was stabilised, not induced, by addition 
of FK-506. Openings to the maximum current level were not 
eliminated by FK-506. Ryanodine locked the FK-506-treated 
channel into the usual substate, which had a conductance that 
was 20-30 pS greater than, and was distinctly different from, 
the FK-506-stabilised substate. Therefore FK-506 did not mod- 
ify the ryanodine binding site. 
Ryanodine receptor calcium release channels in FK-BP defi- 
cient TC display a greater sensitivity to Ca 2÷ for channel activa- 
tion between 10 -7 and 10 -6 M cis [Ca 2÷] and FK-506 has been 
shown to increase the activity of channels in native vesicles at 
nanomolar cis [Ca 2÷] [15]. We find that FK-506 increases the 
Po of ryanodine receptors in native vesicles over the same range 
of [Ca 2÷] and, in addition, alleviates Ca 2÷ inactivation of chan- 
nel activity at 10-3M cis [Ca2÷]. Thus FK-BPI2 may modify 
both the Ca2+-activation a d Ca2÷-inactivation characteristics 
of the channel. 
Calcium-inactivation f calcium release occurs with cyto- 
plasmic alcium concentrations between 10 -4 and 10 -3 M [20]. 
Although bulk myoplasmic [Ca 2÷] seldom approaches these 
levels, [Ca 2÷] near release sites on the TC membrane can rise 
to levels between 10 -4 and 10 -3 M during calcium release [6]. 
Indeed, calcium-inactivation f calcium release has been ob- 
served in cut fibres [23], suggesting that [Ca 2÷] near the release 
channel can rise to levels that produce inactivation during nor- 
mal contraction. 
The mechanism by which FK-BP12 modifies channel gating 
is unknown. The proline isomerase activity suggests a role in 
protein folding and this is supported by the occurrence of 
FK-BPs in many cellular compartments [24-26]. Proline resi- 
dues are found near transmembrane segments of transport pro- 
teins [27] and near the M2 segment of the ryanodine receptor 
[13]. Changing the conformation of peptide chains near the 
transmembrane region could alter channel gating. Alternatively 
FK-BP12 binding to the ryanodine receptor per se may modify 
the conformation of the ion channel and alter its gating. 
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A remote possibility is that the potentiating action of FK-506 
depended on FK-506/FK-BP12 inhibition of endogenous phos- 
phatase activity. The FK-506/FK-BP12 complex binds to and 
inhibits calcineurin, a Ca2+/calmodulin dependent serine/thre- 
onine phosphatase. Phosphorylation of serine-2843 on the skel- 
etal muscle ryanodine receptor activates the calcium channel 
[28]. Binding of the FK-506/FK-BP12 complex to, and inhibi- 
tion of, the phosphatase may increase phosphorylation of 
serine-2843 and thus increase the ryanodine receptor channel 
activity. However, the recent observation that rapamycin has 
the same effect as FK-506 ([29], our unpublished results), makes 
this possibility unlikely, since rapamycin binds to FK-BP12, 
but does not inhibit phosphatase activity. 
In conclusion, FK-506 increases the single channel activity 
of the ryanodine receptor calcium release channel in native TC 
vesicles. The activation occurs at 10 -7 M cis (cytoplasmic) 
[Ca 2+] where channel activity is low, as well as at 10 -5 M cis 
[Ca 2+] where channel activity is high and at 10 -3 M cis [Ca 2+] 
where channel activity is inactivated by cis Ca 2+. It is most likely 
that the activation produced by FK-506 is due to removal of 
an inhibitory influence of FK-BP12. 
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Note added in proof 
A recent publication by Brillantes et al. [29] reports some 
similar findings. 
